
浏览全部资源
扫码关注微信
重庆医科大学感染性疾病分子生物学教育部重点实验室
纸质出版日期:2016,
扫 描 看 全 文
[1]聂丽珠,聂丹,段玉洁,李治,陈震,田玲,唐霓.丙型肝炎病毒核心蛋白抑制E-cadherin基因启动子活性[J].重庆医科大学学报,2016,41(06):547-551.
Nie Lizhu, Nie Dan, Duan Yujie, et al. Hepatitis C virus core protein inhibits the E-cadherin promoter activity[J]. Journal of Chongqing Medical University, 2016,41(6):547-551.
[1]聂丽珠,聂丹,段玉洁,李治,陈震,田玲,唐霓.丙型肝炎病毒核心蛋白抑制E-cadherin基因启动子活性[J].重庆医科大学学报,2016,41(06):547-551. DOI: 10.13406/j.cnki.cyxb.000987.
Nie Lizhu, Nie Dan, Duan Yujie, et al. Hepatitis C virus core protein inhibits the E-cadherin promoter activity[J]. Journal of Chongqing Medical University, 2016,41(6):547-551. DOI: 10.13406/j.cnki.cyxb.000987.
目的:探讨丙型肝炎病毒核心蛋白(hepatitis C virus core protein
HCV core)对E-cadherin启动子活性的调控作用。方法:以Huh7细胞基因组为模板
构建野生型E-cadherin(CDH1)基因启动子荧光素酶报告质粒(pGL3-CDH1)
然后设计突变引物序列将人E-cadherin启动子区负性调控关键区域
即位于-80
-
75 nt(E-box1)
-30
-
25 nt(E-box3)
和+22
+
27 nt(Ebox4)的3个E-box的共识别序列5’-CANNTG-3’突变为5’-AANNTA-3’
分别构建E-box1(pGL3-mut1)、E-box3(pGL3-mut2)、E-box4(pGL3-mut3)、E-box1+3(pGL3-mut1+2)、E-box1+4(pGL3-mut1+3)、E-box3+4(pGL3-mut2+3)、E-box1+3+4(pGL3-mut1+2+3)的荧光素酶报告质粒。将上述质粒与内参质粒p RL-TK分别共转染于过表达核心蛋白的肝癌细胞株SMMC-7721细胞
采用双荧光素酶报告系统检测HCV core对E-cadherin启动子的调控
分析E-cadherin启动子区不同位点的E-box区域在HCV core调控E-cadherin启动子活性中发挥的作用。结果:荧光素酶活性检测结果显示
与GFP对照组相比
HCV core可以明显抑制野生型E-cadherin启动子活性;在E-box单一突变的E-cadherin报告质粒转染细胞中
HCV core对CDH1启动子的抑制作用有不同程度减弱
特别是-80
-
75 nt和-30
-
25 nt位点的E-box区域作用最为明显;E-box联合突变型质粒转染细胞中
HCV core对CDH1启动子的抑制作用明显减弱。结论:HCV core能明显抑制E-cadherin的转录活性
E-box突变可以部分拮抗HCV core对E-cadherin的转录抑制作用
提示位于-80
-
75 nt和-30
-
25 nt位点的E-box保守负性调控区域在HCV core对E-cadherin的转录调控中发挥关键作用。
Objective:To investigate the regulation of hepatitis C virus core protein(HCV core)on E-cadherin promoter activity.Methods:The CDH1 promoter fragment
amplified from the Huh7 cells
was cloned into pGL3-Basic to construct the luciferase report plasmid(pGL3-CDH1). The three E-boxes consensus sequences
which located at-80~-75 nt(E-box1)
-30~-25 nt(E-box3)
and+22~+27 nt(E-box4)in human E-cadherin promoter region
play important role in E-cadherin transcriptional regulation. Thus
mutagenic primers were designed to induce point mutations in three putative E-box sites in the CDH1 promoter sequence. These mutations changed the sequence of the E-boxes from 5’-CANNTG-3’to 5’-AANNTA-3’
which resulted in the insertion of a Snailunrecognized site. These reporter constructs were named E-box1(pGL3-mut1)
E-box3(pGL3-mut2)
E-box4(pGL3-mut3)single mutation types and E-box1+3(pGL3-mut1+2)
E-box1+4(pGL3-mut1+3)
E-box3+4(pGL3-mut2+3)
E-box1+3+4(pGL3-mut1+2+3) mutant constructs respectively. The E-cadherin promoter constructs containing wild-type or mutant E-boxes were co-transfected with p RL-TK(an internal control) into SMMC-7721 cells over expressing HCV core protein respectively
then the luciferase activities were detected. Results:Compared with that of GFP control group
HCV core protein could significantly inhibit wild-type CDH1 promoter activity. In E-box single mutant CDH1 transfection cells
the inhibition of HCV core protein on CDH1 promoter decreased in different degrees. It is most obvious in-80~-75 nt and-30~-25 nt. In compound mutation of CDH1-transfected cells
the HCV core-induced CDH1 inhibition was significantly diminished. Conclusion:HCV Core protein strongly inhibits E-cadherin transcriptional activity. The-80~-75 nt
-30~-25 nt E-boxes consensus sequences within E-cadherin promoter region may play a dominant role in HCV core-induced E-cadherin repression.
肝细胞肝癌丙型肝炎病毒核心蛋白E-cadherinE-box启动子活性
hepatocellular carcinomahepatitis C virus core proteinE-cadherinE-boxpromoter activity
0
浏览量
59
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621